-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

803.P1.79 803. Emerging Tools, Techniques and Artificial Intelligence in Hematology: Poster I

Symposia: Emerging Tools, Techniques and Artificial Intelligence in Hematology Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Translational Research, Clinical Research, Technology and Procedures
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Jan-Niklas Eckardt1,2*, Waldemar Hahn, MSc3,4*, Christoph Röllig, MD, MSc5*, Sebastian Stasik, PhD5*, Uwe Platzbecker, MD6, Carsten Müller-Tidow, MD7*, Hubert Serve, MD8, Claudia D Baldus, MD9*, Christoph Schliemann, MD10*, Kerstin Schäfer-Eckart, MD11*, Maher Hanoun, MD, PhD12*, Martin Kaufmann, MD13, Andreas Burchert, MD14, Christian Thiede, MD5, Johannes Schetelig, MD, MSc5, Martin Bornhäuser, MD5,15*, Markus Wolfien, PhD4* and Jan Moritz Middeke, MD2*

1Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Germany
2Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
3Center for Scalable Data Analytics and Artificial Intelligence (ScaDS.AI) Dresden/Leipzig, Dresden, Germany
4Institute for Medical Informatics and Biometry, Technical University Dresden, Dresden, Germany
5Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
6Department of Hematology, Cell Hematology and Hemostaseology, Leipzig University Hospital, Leipzig, Germany
7Heidelberg University Hospital, Heidelberg, Germany
8Department of Medicine II, Hematology/Oncology, Goethe University Hospital, Frankfurt, Germany
9Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany
10Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
11Department of Internal Medicine V, Paracelsus University Hospital Nuremberg, Nuremberg, Germany
12Department of Hematology, University Hospital Essen, Essen, Germany
13Department of Hematology, Oncology and Palliative Care, Robert Bosch Hospital, Stuttgart, Germany
14Department of Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany
15National Center for Tumor Diseases (NCT/UCC) Dresden, Technical University Dresden, Dresden, Germany

Jan-Niklas Eckardt1,2*, Tim Schmittmann3*, Freya Schulze, MD2*, Sebastian Riechert, MSc1,3*, Martin M. K. Schneider, MD2*, Lukas Reichel, MD2*, Miriam Eva Helena Gediga, MD2*, Katja Sockel, MD2*, Anas Shekh Sulaiman, MD2*, Ekaterina Balaian, MD4*, Christoph Röllig, MD, MSc5*, Frank P. Kroschinsky, MD, MBA2, Anne Marie Asemissen, MD6*, Uwe Platzbecker, MD7, Christian Pohlkamp, MD8*, Torsten Haferlach, MD, PhD8, Karsten Wendt, PhD3*, Martin Bornhäuser, MD9,10* and Jan Moritz Middeke, MD2,11*

1Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Germany
2Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
3Institute of Software and Multimedia Technology, Technical University Dresden, Dresden, Germany
4Department of Medicine I, University Hospital TU Dresden, Dresden, Germany
5Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
6Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
7Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Medical Center Leipzig, Leipzig, Germany
8MLL Munich Leukemia Laboratory, Munich, Germany
9National Center for Tumor Diseases (NCT/UCC) Dresden, Technical University Dresden, Dresden, Germany
10Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
11Else-Kröner-Fresenius-Center for Digital Health, Technical University Dresden, Dresden, Germany

Zoe Sekyonda, BS1*, Cissy Kityo, PhD2*, Yasmin Elgammal, MD, MSc3*, Theodosia A. Kalfa, MD, PhD3, Ozan Akkus, PhD1,4* and Umut A. Gurkan, PhD5,6

1Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH
2The Joint Clinical Research Center, Kampala, Uganda
3Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
4Department of Mechanical and Aerospace Engineering, Case Western Reserve University, Cleveland, OH
5Department of Mechanical and Aerospace Engineering, Case Western Reserve University, Shaker Heights, OH
6Case Western Reserve University, Cleveland, OH

Edgar Baculi, BSc1*, Vineela Kadiyala, PhD2*, Long Tan, BS2*, Bach Nguyen, PhD2*, Nhung Huynh, PhD2*, Tengyao Song2*, Gwo-Jen Day2*, Lin Yuan, MS2*, Michael Bates3 and Huilin Wei, MD, PhD2*

1Hematology Oncology R&D, Cepheid, San Jose, CA
2Hematology Oncology R&D, Cepheid, Sunnyvale, CA
3Cepheid, Sunnyvale, CA

Hiroaki Araie, MD1, Naoko Hosono, MD2, Tetsuya Tsujikawa3*, Hidehiko Okazawa4* and Takahiro Yamauchi, MD, PhD2

1Department of Hematology and Oncology, University of Fukui Hospital, Fukui, Japan
2Department of Hematology and Oncology, University of Fukui, Fukui, Japan
3Department of Radiology, University of Fukui, Fukui, Japan
4Biomedical Imaging Research Center, University of Fukui, Fukui, Japan

Armin Rashidi, MD, PhD1, Suravi Raychaudhuri, MD2, Hakan Gem, DDS, PhD3*, Kristopher A Kerns, PhD3*, Jacob S. Appelbaum, MD, PhD2, Mary-Elizabeth M. Percival, MD2, Anna B. Halpern, MD2, Alexander Zevin, PhD4*, Samuel Minot, PhD5*, David R Dean, DDS6*, Roland B. Walter, MD, PhD, MS2 and Jeffrey S McLean, PhD3*

1Fred Hutchinson Cancer Center, Kirkland, WA
2Fred Hutchinson Cancer Center, Seattle, WA
3School of Dentistry, University of Washington, Seattle, WA
4Genomics Core, Fred Hutchinson Cancer Center, Seattle, WA
5Data Core, Fred Hutchinson Cancer Center, Seattle, WA
6Department of Oral Medicine, Fred Hutchinson Cancer Center, Seattle, WA

Diego Andino1*, Maria Laura Bernaschini1*, Agustina Conrrero1*, María Rita Drocchi1*, Sofia Carbajosa1*, Alejandra Garcia1*, Isolda Isabel Fernandez, MD2*, María Jose Mela Osorio, MD2*, Miguel Arturo Pavlovsky, MD2, Carolina Pavlovsky, MD2*, Silvina Palmer, MD3*, Nicolás Cazap, MD4*, Jorge Solimano, MD4*, Adriana Rinflerch5*, Erika Barbara Brulc, MD5*, Paula González Hermida5*, Andrea Arruda6*, Mark D. Minden7*, Gimena Ferreira1*, Marisa Piaggio8*, Tarek Ali Zaki9*, Gerardo Gatti1*, Candelaria Llorens1* and Gastón Soria, PhD10*

1OncoPrecision, Córdoba, Argentina
2FUNDALEU, Buenos Aires, Argentina
3Hospital Británico, Buenos Aires, Argentina
4CEMIC, Buenos Aires, Argentina
5Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
6Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
7Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
8OncoPrecision, Buenos Aires, Argentina
9OncoPrecision, New York City, NY
10OncoPrecision, Maplewood, NJ

Bruce Seligmann, PhD1*, Salvatore Camiolo, PhD1*, Kathleen Scully, PhD1*, Monica Hernandez, PhD1*, Milos Babic, PhD1*, Joanne Yeakley, PhD1*, Dennis Eastburn, PhD1, Joel McComb1* and Gregory Sahagian, MD2*

1BioSpyder Technologies, Carlsbad, CA
2Neurology Center of Southern California, Carlsbad, CA

Edward Chow, PhD1*, Noor Rashidha Binte Meera Sahib1*, Masturah Rashid2*, Jhin Jieh Lim2*, Wei-Ying Jen, MD, FRCPath, MA3,4* and Melissa Ooi, PhD, FRCPath, MBBChir, MRCP5,6*

1National University of Singapore, Singapore, Singapore
2KYAN Technologies, Singapore, Singapore
3Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5National University Cancer Institute, Singapore, Singapore
6National University Health System, Singapore, Singapore

Sang Mok Park, PhD1*, Yuhyun Ji, PhD1*, Semin Kwon, PhD1*, Jung Woo Leem, PhD1*, Andrew Ross Wickman O'Brien, MD2, Ying Wang, MD, PhD3* and Young L Kim1*

1Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN
2Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN
3Department of Anesthesia, Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN

Linghui Zhou1*, Tao Cheng2, Yongxian HU3* and He Huang, MD4*

1The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
3Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, HANGZHOU, China
4Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China

Naoko Hosono, MD1, Takahiro Yamauchi, MD, PhD1, Chi Sung-Gi2*, Hironori Arai, MD3*, Kentaro Fukushima, MD, PhD4*, Daisuke Ikeda5*, Satoshi Iyama, M.D., Ph.D.6*, Akihiko Gotoh, MD, PhD7, Takayuki Ikezoe, MD, PhD8, Chikashi Yoshida9*, Goichi Yoshimoto, MD, PhD10*, Junya Kanda, MD, PhD11*, Naoto Takahashi, M.D., Ph.D.12, Emiko Sakaida, MD, PhD13, Kensuke Usuki14* and Yosuke Minami, MD, PhD15

1Department of Hematology and Oncology, University of Fukui, Fukui, Japan
2Department of Hematology, National Cancer Center Hospital East,, Kashiwa, JPN
3Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan
4Osaka University Graduate School of Medicine, Suita, Japan
5Division of Hematology/Oncology, Kameda Medical Center, Kamogawa-Shi, CHI, Japan
6Department of Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan
7Department of Hematology, Tokyo Medical University, Tokyo, JPN
8Kochi University, Fukushima, FKS, Japan
9National Hospital Organization Mito Medical Center, Mito, Japan
10Saga-ken Medical Centre Koseikan, Fukuoka, JPN
11Department of Hematology / Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan
12Department of Hematology, Nephrology and Rheumatology, Akita University, Akita, Japan
13Department of Hematology, Chiba University Hospital, Chiba City, Japan
14NTT Medical Center Tokyo,, Department of Hematology, Shinagawa-Ku, TKY, JPN
15National Cancer Center Hospital East, Kashiwa, Japan

Rafael Renatino-Canevarolo, PhD1*, Maria Silva2*, Mark B Meads, PhD3*, Xiaohong Zhao, MD, PhD3*, Alexandra Achille3*, David Noyes3*, Praneeth Reddy Sudalagunta, PhD2*, Raghunandan Reddy Alugubelli3*, Daniel Lastorino4*, Leticia Tordesillas5*, Miguel Gomez Fontela5*, Oliver Hampton, PhD, MSc6*, Daniel Abate-Daga, PhD5*, Kenneth H. Shain, MD, PhD3 and Ariosto Siqueira Silva, PhD2*

1Department of Metabolism and Physiology, H. Lee Moffitt Cancer Center, Tampa, FL
2Department of Metabolism and Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
4NTRO Clinic Research Operations, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
5Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
6Science and Innovation Division, Aster Insights, Tampa, FL

Barbara D Lam, MD**1, Zeshan Hussain, PhD** (co-first authors)2,3*, Fernando A Acosta-Perez4*, Irbaz Bin Riaz, MD, MMSc5*, Maia Jacobs, PhD6*, Andrew J. Yee, MD7 and David Sontag, PhD3*

1Division of Hematology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA
2Harvard Medical School, Boston, MA
3Computer Science & Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA
4Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI
5Division of Hematology and Oncology, Dana-Farber Cancer Institute, Boston, MA
6Department of Computer Science, Northwestern University, Evanston, IL
7Center for Multiple Myeloma, Massachusetts General Hospital, Boston, MA

Juncheng Chen1*, Qingya Cui2*, Mengyun Li2*, Zheng Li2*, De-Pei Wu3, Xiaowen Tang2* and Hongjie Shen4*

1The First Affiliated Hospital of Soochow University, Suzhou, China
2National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
3National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow Univers, Suzhou, China
4National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China, Suzhou, Arkansas, CHN

Jyotsana Singh, PhD1, John R. Sanchez II2*, Chaomei Liu3*, Bailey Slawin3*, Nitin Jain, MD4, William G. Wierda, MD, PhD5, Kai Zhang, MD6*, Michael Niesman, PhD7*, James S. Blachly8, Jennifer A. Woyach, MD9 and Deepa Sampath, PhD3

1Department of Hematopoietic biology and malignancy, University of Texas, MD Anderson Cancer Center, Houston, TX
2University of Texas, MD Anderson Cancer center, Houston
3Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
6MingSight Pharmaceuticals, Irmo, CA
7MingSight Pharmaceuticals, San Diego, CA
8Department of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
9The Ohio State University Comprehensive Cancer Center, Columbus, OH

Christoph Kornauth, MD1*, Valerio Lupperger, PhD1*, Sven Maschek, BA2*, Wolfgang Kern, MD1, Claudia Haferlach, MD1, Torsten Haferlach, MD, PhD1 and Christian Pohlkamp, MD1*

1MLL Munich Leukemia Laboratory, Munich, Germany
2MLL Munich Leukemia Laboratory, Munich, AL, Germany

Renee Higgins, PhD, Michael Adams, MS*, Nick Haase, PhD*, Jessica Igoe, MS*, Rachel Krupa*, Ali Lashgari, PhD*, Ian Levine, MS*, Aaron Palumbo, MS*, Robin Richardson*, Astrid Schroeder, PhD*, Florence Lee, PhD* and Dena Marrinucci, PhD*

Truvian, San Diego, CA

Eudorah Vital, BS1,2, Meredith H. LiCalzi, BS3,4*, Robert Mannino, PhD5*, Patrick T. McGann, MD, PhD6 and Wilbur Lam, MD, PhD7,8

1Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA
2Emory University School of Medicine, Atlanta
3Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta
4Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven
5Sanguina Inc., Atlanta
6Lifespan Comprehensive Sickle Cell Center, Providence, RI
7Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA
8Wallace H. Coulter Department of Biomedical Engineering,, Georgia Institute of Technology and Emory University, Atlanta, GA

Mario Ballerini1*, Michael Heckman, MS1*, Launia White, BS1*, Razan Mohty, MD2, Yenny Vanegas Moreno, MD3*, Hassan Alkhateeb, MD4*, Mohamed A. Kharfan-Dabaja, MD, MBA3, Nandita Khera, MD5, William J. Hogan, MD4, Mark R. Litzow, MD4, Abhishek A Mangaonkar, MBBS4, Hemant S. Murthy, MD3, Jeanne Palmer, MD6, Mithun V Shah, MD, PhD4, Lisa Sproat, MD5, Chris Ray, MD1* and James M. Foran, MD7

1Mayo Clinic, Jacksonville, FL
2Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
3Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
4Division of Hematology, Mayo Clinic, Rochester, MN
5Mayo Clinic, Phoenix, AZ
6Mayo Clinic - Arizona, Scottsdale, AZ
7Hematology/Oncology, Mayo Clinic, Jacksonville, FL

Shahanawaz Jiwani, MD, PhD, MS1*, Jerald P. Radich, MD2, Maria Saeed3*, Lauri Aicher4*, Ting-Chia Chang1*, Srikrishna Narava3*, Zaneta Holman4*, Lan Beppu5*, Olga Sala-Torra, MD5*, Marvin Majano3*, Erin Taylor3*, Laura Yee3*, Jessica Li3*, Lisa McShane6*, Pooja CS Sanduria4*, Paul Mickey M. Williams, PhD7 and Cecilia C.S. Yeung, MD5

1NIH, Frederick, MD
2Translational Sciences & Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
3NIH, Frederick
4Fred Hutch Cancer Center, Seattle, WA
5Fred Hutchinson Cancer Center, Seattle, WA
6National Cancer Institute, Bethesda, MD
7Frederick National Labs For Cancer Research, Frederick, MD

Sarthak Satpathy1*, Beena Thomas, PhD2,3*, William Pilcher4*, Mojtaba Bakhtiari, MD3*, Lori A. Ponder5*, Rafal Pacholczyk, PhD6*, Sampath Prahalad, MD3,5,7*, Swati Bhasin, PhD2,3, David H. Munn, MD6,8* and Manoj Bhasin, PhD1,2,3,4

1Department of Biomedical Informatics, Emory University, Atlanta, GA
2Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
3Department of Pediatrics, Emory University, Atlanta, GA
4Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA
5Children's Healthcare of Atlanta, Atlanta, GA
6Georgia Cancer Center, Augusta, GA
7Department of Human Genetics, Emory University, Atlanta, GA
8Department of Pediatrics, Augusta University, Augusta, GA

Swati Kushal1*, Kyle Calayag2*, Suvarthi Das2*, Behnaz Saatian2*, Guanyi Xie2*, Michael Bates1 and Gwo-Jen Day3*

1Cepheid, Sunnyvale, CA
2Cepheid, Sunnyvale
3Hematology Oncology R&D, Cepheid, Sunnyvale, CA

Francisco Javier Borrayo López1,2,3*, Izchel Figarola Centurion, B.S.4,5,6*, Francisco Javier Perea Díaz, Ph.D7*, César Millán Pacheco, Ph.D8*, Bertha Ibarra Cortés, Ph.D9*, Blanca Miriam Torres Mendoza, Ph.D10*, Juan Antonio Flores-Jimenez, PhD11 and Lourdes Del Carmen Rizo-De La Torre, PhD12*

1Doctorado en Genética Humana, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UDG), GUADALAJARA, Mexico
2Division de Medicina Molecular, Centro de Investigación Biomedica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajada, JA, Mexico
3División de Genética, Centro de Investigación Biomedica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, JA, Mexico
4Doctorado en Genética Humana, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UDG), Guadalajara, JA, Mexico
5División de Neurociencias, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Gaudalajara, JA, Mexico
6División de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro social (IMSS), Guadalajara, JA, Mexico
7División de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, JA, Mexico
8Universidad de Farmacia, Universidad Autónoma del Estado de Morelos, Morelos, Mexico
9Instituto de Genética Humana “Dr. Enrique Corona Rivera", Centro Universitatio de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Guadalajara, JA, Mexico
10División de Neurociencias, Centro de Investigación Biomedica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), GUADALAJARA, JA, Mexico
11Centro Universitario de Tonalá, Universidad de Guadalajara (UdeG), Tonalá, Jalisco, MEX
12División de Medicina Molecular, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, MEX

Mariya Liyasova, PhD1*, Michael Slade, MD, MSCI2, Julie Fortier, PhD2*, Ravi Vij, MD, MBA2, Mark Fiala, PhD2*, Liqiang Yang, PhD3* and Bin Ma, PhD1

1Rapid Novor Inc., Kitchener, ON, Canada
2Division of Oncology, Washington University School of Medicine, Saint Louis, MO
3Rapid Novor, Kitchener, ON, Canada

Stacey A Cranert, PhD*, Hubert Tseng, PhD*, Karl Marquez*, Benjamin S Cho*, Andrew Bacong*, Danny Mendoza*, Garrett Arauz*, Nick DeMarco*, Mona Connerney, MD, PhD*, Julia Coronella, PhD* and Devon J Shedlock, PhD

Poseida Therapeutics, San Diego, CA

Spencer Krichevsky, MS1,2*, Madhu M Ouseph, MD, MBBS, PhD3*, Yuwei Zhang, MS1*, Ghaith Abu-Zeinah, MD2, Joseph M. Scandura, MD, PhD, MS2 and Rajarsi Gupta, MD, PhD1*

1Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY
2Richard T. Silver, MD Myeloproliferative Neoplasms Center, Weill Cornell Medicine, New York, NY
3Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY

*signifies non-member of ASH